BACKGROUND OF THE INVENTION
Field of the Invention
The present invention in general relates to probiotic formulations and their therapeutic effects. In specific, the present invention discloses a process for the therapeutic management of diarrhea predominant irritable bowel syndrome in humans
TECHNICAL FIELD
The present invention relates to a pharmaceutical agent containing (S)-1-cyclopropyl-1,4-dihydro-7-[2-(N,N-dimethylaminomethyl)morpholino]-6- fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof, which agent is useful for the prophylaxis and
FIELD OF THE INVENTION
The present invention relates to the development of platform technology for targeted, controlled delivery of oral enhanced probiotics for various indications, including for example the active and prophylaxis treatment of Clostridium difficile Infection as well as Metabolic
FIELD OF THE INVENTION
The present invention relates to the development of platform technology for targeted, controlled delivery of oral enhanced probiotics for various indications, including for example the active and prophylaxis treatment of Clostridium difficile Infection as well as Metabolic
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to therapeutic treatment of infectious gastroenteritis.
2. Description of the Related Art
Normal microflora is important in the protection of the host against diseases of the gastrointestinal (GI) tract (Fuller, R., Gut
FIELD OF THE INVENTION
The invention relates to a novel method of preventing or reducing intestinal tract fluid secretions and losses of fluids and electrolytes in a mammalian subject by administering thereto an effective dosage of an enantiomer of histidine or a mixture of histidine enantiomers and
FIELD OF INVENTION
This invention relates to the treatment of Clostridium difficile associated diseases such as Clostridium difficile colitis, pseudomembranous colitis and antibiotic associated diarrhea by administration of specific antibodies in the form of oral and/or pharmaceutical
1. FIELD OF THE INVENTION
The present invention relates to 4-Tetrazolyl-4-phenylpiperidine Compounds, compositions comprising an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound and methods for preventing or treating pain or diarrhea in an animal comprising administering to an animal
1. FIELD OF THE INVENTION
The present invention relates to 4-Tetrazolyl-4-phenylpiperidine Compounds, compositions comprising an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound and methods for preventing or treating pain or diarrhea in an animal comprising administering to an animal
1. FIELD OF THE INVENTION
The present invention relates to 4-Tetrazolyl-4-phenylpiperidine Compounds, compositions comprising an effective amount of a 4-Tetrazolyl-4-phenylpiperidine Compound and methods for preventing or treating pain or diarrhea in an animal comprising administering to an animal
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a therapeutic method, more particularly, to a therapeutic method for diseases such as intractable diseases including multiple sclerosis, acute gastroenteritis, viral hepatitis and the like, which are caused by
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a prophylactic and therapeutic composition for inhibiting rotavirus infection, and more particularly to a method of preventing and treating diseases or conditions associated with, or requiring, rotavirus infection, using
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to diarylmethyl piperazine compounds having utility in medical therapy especially as receptor-binding species, e.g., as conjugates in agonist/antagonist pairs for verifying/assaying receptor and neurotransmitter
Den mest komplette databasen med medisinske urter støttet av vitenskap
Fungerer på 55 språk
Urtekurer støttet av vitenskap
Urtegjenkjenning etter bilde
Interaktivt GPS-kart - merk urter på stedet (kommer snart)
Les vitenskapelige publikasjoner relatert til søket ditt
Søk medisinske urter etter deres effekter
Organiser dine interesser og hold deg oppdatert med nyheter, kliniske studier og patenter
Skriv inn et symptom eller en sykdom og les om urter som kan hjelpe, skriv en urt og se sykdommer og symptomer den brukes mot. * All informasjon er basert på publisert vitenskapelig forskning